Annotation Detail for SCUBE1

Basic Information
Top
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016047 |
Zalcitabine |
[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of SCUBE1 mRNA | affects cotreatment|increases expression | 18606552
|
C514793 |
gp120 protein, Human immunodeficiency virus 1 |
[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of SCUBE1 mRNA | affects cotreatment|increases expression | 18606552
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D009202 |
Cardiomyopathies |
|
Zalcitabine |
5.01 | 10591146 |
MESH:D004362 |
Drug Toxicity |
|
Zalcitabine |
5.21 | 7515130 |
MESH:D005234 |
Fatty Liver |
|
Zalcitabine |
5.30 | 18299183 |
MESH:D015658 |
HIV Infections |
|
Zalcitabine |
4.55 | 17457083 |
MESH:D008223 |
Lymphoma |
|
Zalcitabine |
4.98 | 11980663 8840982 18798262 9205081 17941976 8764131 9488045 |
MESH:D009374 |
Neoplasms, Experimental |
|
Zalcitabine |
5.86 | 9205081 9488045 8764131 |
MESH:D009437 |
Neuralgia |
|
Zalcitabine |
7.20 | 17292584 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
gp120 protein, Human immunodeficiency virus 1 |
13.28 | 18606552 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Zalcitabine |
13.28 | 18606552 |